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Electrical abnormalities within the heart can often result in the development of arrhythmias 30 which may further progress into sudden cardiac death; often the origins of these developments 31 remain largely unknown. Atrial fibrillation, which is one of the most common type of heart 32 arrhythmia affects an estimated 3-6 million people within the United States (CDC). Arrhythmic 33 events can arise in atria and or the ventricular regions of the heart often developing from genetic 34 mutations, in particular from genes encoding important ion channels such as sodium and or 35 potassium channels and their auxiliary subunits. Research in the field of arrhythmic study 36 identified key ion channels such as sodium and potassium channels highlighting the clinical 37
importance of mutations such as in the SCN5A channel (32). However, to date, potassium 38 channel mutations as well as their auxiliary subunits alterations are less known and therefore 39 remain important and clinically relevant targets for investigation. One particular group of 40 potassium channels of interest are the voltage activated potassium (Kv) channels which play a 41 critical role in establishing the repolarization phase of cardiac action potentials. In addition, they 42 are one of the key channels affected in action potential prolongation as well as in QT 43 prolongation. The human genome encodes roughly 40 different Kv channels which are further 44 subdivided into twelve sub-families (Kv1-Kv12). They share a general channel mechanism i.e., 45 sensing voltage changes within the cell and responding by activating/inactivating or closing 46 dependent upon the channel properties. Kv channels open, inactivate and close in response to 47 voltages and this synchrony of Kv channel action works in continuous balance in order to 48 propagate action potentials. Previous research identified that mutations of fast inactivating Kv 49 currents (Murine-Kv4.2 Human-Kv4.3 channels) demonstrated significant prolongation in QT 50 durations, resulted in cardiac hypertrophy and even heart failure (4, 23). Mutations in other 51 cardiac relevant Kv channels such as Kv2.1, 1.5 and, 1.4 produced similar deleterious effects, 52 altering QT durations with little to no effect demonstrated on cardiac remodeling (16, 17) . 53
54
Kv channel auxiliary subunit modulation has had profound effects on regulating Kv channel 55 activity which is sometimes even greater than mutations or deletions of the potassium channel 56 (11, 19, 31) . The auxiliary subunits or otherwise known β subunits Kvβ (Shaker potassium 57 channel subunit) include Kvβ1 (with splice variants Kvβ1.1, Kvβ1.2, and Kvβ1.3) and Kvβ2. 58
These Kvβ subunits are of particular interest in the cardiovascular system because they are 59 highly expressed within the heart and vascular system including the aorta (7, 25) . In vitro work 60 has demonstrated profound effects of Kvβ subunits on Kv channel activity although little is 61 known about the in vivo effects of Kvβ subunit alterations. Kvβ1 subunits have been shown to 62 modulate key Kv channels including Kv1.5, 1.4 and most recently 4.2 all of which play a vital 63 role in the repolarization of cardiac action potentials (8, 25, 30) . Kvβ1 knockout mice have 64 significant decrease in I to'f current as well as the I to's current (1). More recent genetic testing is 65 beginning to reveal the absence of Kvβ's in numerous disease conditions including 66 schizophrenia, high blood pressure, and sudden cardiac death (3, 5, 12, 14) . 67
68
Initial discoveries demonstrated high levels of Kvβ subunits in brain and abundant expression in 69 the heart as well as the vascular system (7). The cloning, isolation, purification and X-ray 70 crystallography work led to the understanding of the sequence and structure of the Kvβ subunits 71 (9). The sequence alignment analysis showed that Kvβ subunits shared similarities with the 72 oxidoreductases, in particular the aldo-keto reductases (AKR) (15). Because of the closely 73 related sequence to AKR5 and AKR7 subfamilies, the Kvβ subunits were later classified as 74 AKR6 (10). Furthermore, the Kvβ subunits were recognized as the only protein with dual 75 functions, both as an enzyme as well as modulator of Kv channels. These distinct 76 characteristics categorized Kvβ subunits to an elite group of proteins known to us in nature. In 77 addition, the unique ability of Kvβ subunits as reductase enzyme which convert carbonyls 78 (aldehydes or ketones) to their respective alcohols shared the central feature of AKR's proteins 79
i.e., the ability to bind pyridine nucleotides (NAD/NADH and NADP/NADPH) with high affinity. 80
To this context, the findings by Tur and colleagues reported in the current issue of the journal 81 that Kvβ1.1 interacts with NADH/NAD and alters cardiac electrical activity are highly novel. 82 Subsequent research focused on understanding the Kvβ structure culminating in the crystal 83 structure of a truncated Kvβ2 subunit which remained bound to the NADP + molecule during the 84 crystallization process (9). In addition to the pyridine nucleotide binding abilities, the Kvβ1 85 subunits with their varying NH 2 -termini demonstrated the potential to rapidly inactivate non-86 inactivating Kv channels (2, 29). Moreover, even fast inactivating Kv channels such as Kv1.4 as 87 well as Kv4.2/4.3 could be modulated by Kvβ1 subunits (6, 20, 22) . 88
89
Much like the other oxidoreducastases the Kvβ subunits maintained substrate binding sites and 90 cofactor binding pockets. While it was understood that pyridine nucleotides could bind to Kvβ 91 subunits at low micromolar concentrations, little was known as to how this binding altered Kv 92 channel or Kvβ activity in cardiovascular physiology. The binding affinity (Kd) of pyridine 93 nucleotides and Kvβ subunits was found to be in the micro molar range (13, 26) . In addition 94 flavin adenine dinucleotide (FAD) and nicotinamide mononucleotide (NMN) also bind to the Kvβ 95 subunits but required significantly higher concentrations (13) . To this end, a link between 96 pyridine nucleotide binding, Kvβ subunits and their modulation of Kv channels remained 97 unknown. Kv1.5 and the addition of Kvβ1 in the presence and absence of pyridine nucleotides 98 significantly altered Kv1.5 channel activity; high levels of NADH increased inactivation rates 99 while high NAD caused the channel to remain active (27). AKR's catalytic activity utilizes a 100 hydride transfer and thus requires pyridine nucleotides for modulation (24) were thought to be a silent partner for many decades. Thus, this elegant work by Tur and 124 colleagues brings the Kvβ subunits to the forefront of cardiovascular research and its potential 125 impact in modulating the electrical activity of the heart in a physiologically relevant manner. 
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